NYSEARCA:PILL Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL) Price, Holdings, & News $8.90 -0.16 (-1.77%) (As of 11/4/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsRatings About Direxion Daily Pharmaceutical & Medical Bull 3X Shares (NYSEARCA:PILL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get PILL alerts:Sign Up Key Stats Today's Range$8.84▼$9.0550-Day Range$7.64▼$9.7952-Week Range$4.57▼$9.84Volume76,418 shsAverage Volume76,346 shsMarket Capitalization$20.47 millionAssets Under Management$14.91 millionDividend Yield0.67%Net Expense Ratio1.01%Aggregate RatingModerate Buy ETF OverviewThe Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (PILL) is an exchange-traded fund that is based on the S&P Pharmaceuticals Select Industry index. The fund provides 3x daily exposure to a modified equal-weighted index of pharmaceutical companies in the US. PILL was launched on Nov 15, 2017 and is managed by Direxion.Read More… Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Direxion Daily Pharmaceutical & Medical Bull 3X Shares ExpensesTypePILLHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.75%0.56%0.55%0.51%0.52%Other Expenses0.78%0.33%0.49%0.58%0.53%Total Expense1.53%0.71%0.71%0.73%0.71%Fee Waiver-0.52%-0.45%-0.52%-0.67%-0.57%Net Expense1.01%0.61%0.61%0.58%0.59% Receive PILL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Direxion Daily Pharmaceutical & Medical Bull 3X Shares and its competitors with MarketBeat's FREE daily newsletter. Email Address PILL ETF News HeadlinesDirexion Daily 20+ Year Treasury Bull 3X Shares declares quarterly distribution of $0.4350September 24, 2024 | msn.comDirexion Daily Pharmaceutical & Medical Bull 3X Shares declares quarterly distribution of $0.0219September 24, 2024 | msn.comCharles Payne Wants You Prepared for Q4Charles Payne Wants You Prepared for Q4 Because as we look toward 2025, there's no denying that market volatility, inflation, and recession fears are top of mind for every investor Now more than ever, it's crucial to have a solid plan for navigating uncertainty and coming out ahead. November 5, 2024 | Unstoppable Prosperity (Ad)CURE Direxion Daily Healthcare Bull 3X Shares ETFSeptember 22, 2024 | seekingalpha.comDirexion Daily Transportation Bull 3X Shares (TPOR)May 25, 2024 | investing.comFirst Trust Nasdaq Pharmaceuticals ETF declares $0.0676 dividendMarch 27, 2024 | msn.comSee More Headlines PILL ETF - Frequently Asked Questions How have PILL shares performed this year? Direxion Daily Pharmaceutical & Medical Bull 3X Shares' stock was trading at $7.75 at the beginning of the year. Since then, PILL shares have increased by 14.8% and is now trading at $8.90. View the best growth stocks for 2024 here. How do I buy shares of Direxion Daily Pharmaceutical & Medical Bull 3X Shares? Shares of PILL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Direxion Daily Pharmaceutical & Medical Bull 3X Shares own? Based on aggregate information from My MarketBeat watchlists, some other companies that Direxion Daily Pharmaceutical & Medical Bull 3X Shares investors own include Walt Disney (DIS), Meta Platforms (META), Aurora Cannabis (ACB), Affirm (AFRM), BILL (BILL), Direxion Daily S&P Biotech Bull 3x Shares (LABU) and Eli Lilly and Company (LLY). Fund Details IssuerDirexion Fund NameDirexion Daily Pharmaceutical & Medical Bull 3X Shares Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:PILL Inception Date11/15/2017 Fund ManagerPaul Brigandi, Tony Ng WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkS&P Pharmaceuticals Select Industry Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings54 Fund Statistics Assets Under Management$14.91 million Average Daily Volume$44,838.20 Discount/Premium0.03% Leveraged3.00 Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorRafferty Asset Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerIMC Options OptionableOptionable Options Volume14 Put Options2 Call Options14 Short Interest48,300 shs Miscellaneous Outstanding Shares2,300,000Beta2.45 Creation Unit50,000 Creation Fee$250.00 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Top 10 PILL HoldingsS&P PHARMACEUTICALS SELECT INDEX SWAPHolding Weight: 105.81%S&P PHARMACEUTICALS SELECT INDEX SWAPHolding Weight: 65.70%S&P PHARMACEUTICALS SELECT INDEX SWAPHolding Weight: 52.99%DREYFUS GOVT CASH MAN INSHolding Weight: 9.54%GOLDMAN FINL SQ TRSRY INST 506Holding Weight: 6.10%Corcept Therapeutics (NASDAQ:CORT)Holding Weight: 3.13%Longboard Pharmaceuticals (NASDAQ:LBPH)Holding Weight: 3.11%Bristol-Myers Squibb (NYSE:BMY)Holding Weight: 2.83%Jazz Pharmaceuticals (NASDAQ:JAZZ)Holding Weight: 2.69%Catalent (NYSE:CTLT)Holding Weight: 2.68%Full Holdings DetailsPILL Sector ExposurePILL Industry Exposure This page (NYSEARCA:PILL) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily Pharmaceutical & Medical Bull 3X Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily Pharmaceutical & Medical Bull 3X Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
